Target intelligence / Profile preview

Chromosome 2 open reading frame 42 (C2orf42)

Target
C2orf42
Molecular classification
Other (protein-coding gene, not assigned to a known receptor, enzyme, transporter, or transcription factor family)
01

Overview

Chromosome 2 open reading frame 42 (C2orf42) encodes a protein of unknown specific function, located primarily in the nucleoplasm. Emerging research suggests context-dependent roles in human disease: - Suppression of C2orf42 in renal epithelial cells during oxygen and glucose deprivation improves cell survival and lessens cisplatin toxicity, indicating that the gene may contribute to cellular stress responses in kidney injury. - A rare clinical case identified an ALK–C2orf42 gene rearrangement in aggressive pediatric melanoma, suggesting a possible role in oncogenic transformation through altered transcriptional regulation. This implies that C2orf42 can be involved in disease processes when aberrantly regulated [1]. - The gene may also play a part in neuronal development, though data supporting this is presently hypothetical and unconfirmed [2]. No validated therapeutic targeting, molecular family classification, or clinical safety profile for C2orf42 currently exists. Its disease association is primarily reported through functional screens and rare fusion events, rather than direct pharmacological targeting [1][2][3].

Other names
C2orf42FLJ20558CB042_HUMANUncharacterized protein C2orf42
02

Mechanism of action

None established—no drugs known to target C2orf42

03

Biological functions

Cellular stress response (context-dependent)—may promote cell injury in renal ischemiaPossible involvement in transcriptional regulation through fusion events (e.g., ALK–C2orf42 rearrangement in melanoma)Hypothetical roles in neuronal development or differentiation (low basal expression in mature neurons)
04

Disease associations

Renal injury/aggravationAggressive melanoma phenotype (via ALK–C2orf42 rearrangement)Other: potential role in developmental processes in neurons (hypothetical)

Beyond the preview

Go deeper on Chromosome 2 open reading frame 42 (C2orf42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 2 open reading frame 42 (C2orf42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call